Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
[PMID: 3100446] PubMed record related to this compound for laboratory literature review
Contact us now to speak with a member of our legal team about your potential GLP-1 claim in a free initial consultation.
Specifications Retatrutide is a synthetic peptide engineered as a balanced agonist at three metabolic receptors simultaneously: GIP, GLP-1, and glucagon
Tumor-Specific Activation Linkers should be engineered to respond exclusively to biological signals prevalent in the tumor microenvironment, such as elevated enzymatic activity or acidic pH, to ensure selective drug release
US$ 24.08
US$ 22.33
US$ 29.47
US$ 22.57
US$ 24.55
:format(jpg)/f.elconfidencial.com%2Foriginal%2Ff27%2Fb3a%2F460%2Ff27b3a460e92bcdc8635b6aa1b0eff12.jpg)
US$ 27.84
US$ 22.08
US$ 20.72
US$ 24.07
